Vestal Point Capital, LP

Position in NYXH — Nyxoah SA

CIK 1974915 NEW YORK, NY

Position in NYXH

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$2,536,490

-$2,555,710 QoQ

Shares Held

868,661

-21.5% QoQ

Ownership

0.868%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2024

6 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Vestal Point Capital, LP holds $196,951,519 across 5 Medical Instruments & Supplies names. NYXH ranks #5 (1.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RGEN	Repligen Corp	925,000	$108,983,500
2	ALC	Alcon Inc	800,000	$60,280,000
3	WST	West Pharmaceutical Services Inc	75,000	$18,798,000
4	AVR	Anteris Technologies Global Corp.	1,144,780	$6,353,529
5	NYXH	Nyxoah SA This page	868,661	$2,536,490

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,536,490	868,661	-21.5%	Shares	Sole	2026-05-15
2025-12-31	$5,092,200	1,107,000	-0.0%	Shares	Sole	2026-02-17
2025-09-30	$5,094,099	1,107,413	-21.0%	Shares	Sole	2025-11-14
2025-06-30	$10,486,974	1,402,002	-39.5%	Shares	Sole	2025-08-14
2025-03-31	$16,186,298	2,318,954	-20.7%	Shares	Sole	2025-05-15
2024-12-31	$23,393,728	2,924,216	—	Shares	Sole	2025-02-14
No filing history on record for this holder in this stock.